21119719

Source:http://linkedlifedata.com/resource/pubmed/id/21119719

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013232, umls-concept:C0872152
pubmed:issue	12
pubmed:dateCreated	2010-12-1
pubmed:abstractText	Interest in developing drugs for rare diseases has increased substantially in recent years. This article from the US Food and Drug Administration highlights the role of regulators in catalysing further progress in this field.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21119719-21060315
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101124171
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1474-1784
pubmed:author	pubmed-author:CotéTimothy RTR, pubmed-author:PariserAnne RAR, pubmed-author:XuKuiK
pubmed:issnType	Electronic
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	901-2
pubmed:meshHeading	pubmed-meshheading:21119719-Animals, pubmed-meshheading:21119719-Drug Approval, pubmed-meshheading:21119719-Drug Discovery, pubmed-meshheading:21119719-Humans, pubmed-meshheading:21119719-Orphan Drug Production, pubmed-meshheading:21119719-Rare Diseases, pubmed-meshheading:21119719-United States, pubmed-meshheading:21119719-United States Food and Drug Administration
pubmed:year	2010
pubmed:articleTitle	Accelerating orphan drug development.
pubmed:affiliation	Office of the Commissioner, Office of Orphan Products Development, Silver Spring, Maryland 20993, USA. timothy.cote@fda.hhs.gov
pubmed:publicationType	Journal Article, Comment